Clinical Trial Update: Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy [Phase 2]

View source ↗

Summary

This phase 2 clinical trial evaluates the clinical and biological activity of the anti-PD-L1 antibody atezolizumab in patients with operable localized soft tiss…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Tecentriq (atezolizumab)

Snippet

Sponsor: Centre Leon Berard | Conditions: Sarcoma,Soft Tissue | Phase 2 | Status: ACTIVE_NOT_RECRUITING